For PE, M&A, and federal diligence teams
Federal revenue diligence on Janssen Biotech
You're already in diligence on Janssen Biotech. SCOUT pulls recompete exposure, protest history, agency concentration, and sustain rates from the public record, so that part of the work is an afternoon.
This brief is for
Janssen Biotech
UEI NVYMGFA53MN7 · $1.5M obligated · 46 awards · Department of Veterans Affairs (VA)
Federal revenue diligence on Janssen Biotech
Work email. This brief is for Janssen Biotech. Two figures on this page, the rest in your inbox — recompete cliff, concentration, protest posture.
Here for capture, not diligence? Public intel stays free. The FY27 Sprint is ten Pursuit Analyses with the durability read on each.
What you get on a target
Recompete exposure
Which awards age out, when the window opens, and how much of trailing revenue sits on a clock.
Protest history
Sustain rates and protest posture on the vehicles and agencies the target actually lives on.
Agency concentration
Where the dollars sit — sole-agency risk versus a diversified book.
Sustain rates
How often incumbents hold the work. The number that decides whether a thesis is a roll-up or a cliff.
Looking up a specific contractor? Search public company profiles. Diligence is a motion under Who it's for— not a peer ICP to capture teams.